National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 7) (PB 89 of 2018) (Cth)

PB 89 of 2018

National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 7)

National Health Act 1953

___________________________________________________________________________

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated   25  September 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 7).

(2)This Instrument may also be cited as PB 89 of 2018.

1. Commencement

This Instrument commences on 1 October 2018.

1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

1. Schedule 1, entry for Citalopram

omit from the column headed “Claimed Price”:   8.15        substitute:             9.65

1. Schedule 1, entry for Diazepam in the form Tablet 5 mg

omit from the column headed “Claimed Price”:   3.33        substitute:             4.36

1. Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)

omit from the column headed “Claimed Price”:   9.85        substitute:             11.35

1. Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)

omit from the column headed “Claimed Price”:                              10.19     substitute:             11.69

1. Schedule 1, entry for Gliclazide

omit from the column headed “Claimed Price”:                              12.89     substitute:             13.82

1. Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

omit from the column headed “Claimed Price”:   12.89     substitute:             13.82

1. Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 2.5 mg

omit from the column headed “Claimed Price”:   11.03     substitute:             11.96

1. Schedule 1, entry for Olmesartan with hydrochlorothizide

omit from the column headed “Listed Drug”:                  Olmesartan with hydrochlorothizide      substitute:             Olmesartan with hydrochlorothiazide

1. Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 2.5 mg

omit from the column headed “Claimed Price”:   7.31        substitute:             8.24

1. Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 5 mg

omit from the column headed “Claimed Price”:   8.25        substitute:             9.18

1. Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 10 mg

omit from the column headed “Claimed Price”:   10.10     substitute:             11.03

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing perindopril arginine 5 mg with 5 mg amlodipine (as besilate)

omit from the column headed “Claimed Price”:   9.18        substitute:             10.12

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing perindopril arginine 5 mg with 10 mg amlodipine (as besilate)

omit from the column headed “Claimed Price”:   10.11     substitute:             11.05

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing perindopril arginine 10 mg with 5 mg amlodipine (as besilate)

omit from the column headed “Claimed Price”:   11.03     substitute:             11.96

1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing perindopril arginine 10 mg with 10 mg amlodipine (as besilate)

omit from the column headed “Claimed Price”:   11.96     substitute:             12.89

1. Schedule 1, entry for Perindopril with indapamide in the form Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg

omit from the column headed “Claimed Price”:   8.24        substitute:             9.17

1. Schedule 1, entry for Perindopril with indapamide in the form Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg

omit from the column headed “Claimed Price”:   9.18        substitute:             10.12

1. Schedule 1, entry for Rabeprazole in each of the forms: Tablet containing rabeprazole sodium 10 mg (enteric coated); and Tablet containing rabeprazole sodium 20 mg (enteric coated)

omit from the column headed “Claimed Price”:   6.50        substitute:             7.49

1. Schedule 1, entry for Salbutamol in the form Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

omit from the column headed “Claimed Price”:   3.11        substitute:             4.04

1. Schedule 1, entry for Salbutamol in the form Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

omit from the column headed “Claimed Price”:   3.23        substitute:             4.16

1. Schedule 1, omit entry for Trimethoprim with sulfamethoxazole in the form Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL

1. Schedule 1, after entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg

insert:

Valsartan	Tablet 40 mg	Oral	Diovan	28	4.56	6.56
Tablet 80 mg	Oral	Diovan	28	6.65	8.65
Tablet 160 mg	Oral	Diovan	28	8.54	10.54
Tablet 320 mg	Oral	Diovan	28	10.95	12.95